tiprankstipranks
AstraZeneca Pharma India Limited (IN:ASTRAZEN)
:ASTRAZEN
India Market

AstraZeneca Pharma India Limited (ASTRAZEN) Income Statement

Compare
3 Followers

AstraZeneca Pharma India Limited Income Statement

Last quarter (Q1 2024), AstraZeneca Pharma India Limited's total revenue was ₹3.88B, an increase of 31.16% from the same quarter last year. In Q1, AstraZeneca Pharma India Limited's net income was ₹-117.90M. See AstraZeneca Pharma India Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
₹ 12.96B₹ 10.03B₹ 8.06B₹ 8.09B₹ 8.32B
Gross Profit
₹ 6.22B₹ 5.45B₹ 4.48B₹ 4.78B₹ 4.97B
Operating Expenses
₹ 2.47B₹ 4.94B₹ 3.78B₹ 3.62B₹ 3.95B
Depreciation and Amortization
₹ 149.40M₹ 162.60M₹ 169.50M₹ 197.50M₹ 185.80M
EBITDA
₹ 2.36B₹ 1.51B₹ 1.01B₹ 1.48B₹ 1.34B
Operating Income
₹ 4.47B₹ 945.09M₹ 814.60M₹ 1.26B₹ 1.15B
Other Income/Expenses
₹ -2.28B₹ -168.90M₹ 133.90M₹ 108.30M₹ 114.10M
Pretax Income
₹ 2.20B₹ 1.34B₹ 830.40M₹ 1.27B₹ 1.14B
Net Income
₹ 1.62B₹ 992.90M₹ 616.00M₹ 933.00M₹ 722.10M
Per Share Metrics
₹ ―₹ ―₹ ―₹ ―₹ ―
Basic EPS
₹ 64.60₹ 39.72₹ 24.64₹ 37.32₹ 28.88
Diluted EPS
₹ 64.60₹ 39.72₹ 24.64₹ 37.32₹ 28.88
Weighted Average Shares Outstanding
25.00M 25.00M 25.00M 25.00M 25.00M
Weighted Average Shares Outstanding (Diluted)
25.00M 25.00M 25.00M 25.00M 25.00M
Currency in INR

AstraZeneca Pharma India Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis